ESC Form for "Ongoing Trials"

There will be no review process for “Ongoing Trials” and it will be published a few days after submitting on our website!
Ongoing Trials  will be accepted exclusively for poster presentations!
 Deadline 10 May 2012!

Follow the fields carefully.
Obligatory information is indicated by stars ( * ) coloured in red.

Submitting Person:
                                                                                                                      

*Password:    (Please use 5-20 letters)   *Date:  (mm.dd.jjjj)
 

*First names (initials only: example A.A.):    *Last name: 

*Street:   *Number:  

*Zipcode:   *City:  

*Country: 

*E-mail: 
I
t is important that you enter your e-mail address accurately! Please inform us about any changes immediately!
 

*Phone:        *Fax:

 


Abstract Details:
 
                                                                                                                                                                                                                
*Presentation  
  
   
*Subject area/Topic:  
 

*Abstract title

 
Max. 200
characters/signs, including blanks!
 

*Abstract  text

Max. 2000
characters/signs, including blanks!
Tables and graphics/figures are to be submitted separately after successful abstract submission via email including the AID.
Avoid complex mathematical formulae. For the plus minus symbols, type +/- instead of ±
Avoid Greek letters and symbols, e.g.  'IFN-g' or 'IFN-gamma'.

 

 


 

Trialists:  

 


*1. Presenting Author                                                                                                                                                                             

*Mrs./Mr.:      *Academic title:       *Age:  
*First names (initials only: example A.A.):  
 *Last name: 
*Institution:  
*
City:
*Country:  

*E-mail presenting auhtor:  
It is important that you enter your e-mail address accurately! Please inform us about any changes immediately!  


2. Co-Author:
First names (initials only: example A.A.):  
Last name:
Institution:
City:
Country:


3. Co-Author:
First names (initials only: example A.A.):  
Last name:
Institution:
City:
Country:


4. Co-Author:
First names (initials only: example A.A.):  
Last name:
Institution:
City:
  Country:


5. Co-Author:
First names (initials only: example A.A.):  
Last name:
Institution:
City:
Country:


6. Co-Author:
First names (initials only: example A.A.):  
Last name:
Institution:
City:
  Country:


7. Co-Author:
First names (initials only: example A.A.):
Last name:
Institution:
City:
Country:


8. Co-Author:
First names (initials only: example A.A.):
Last name:
Institution:
City:
Country:


9. Co-Author:
First names (initials only: example A.A.):
Last name:
Institution:
City:
Country:


10. Co-Author:
First names (initials only: example A.A.):
Last name:
Institution:
City:
Country:


11. Co-Author:
First names (initials only: example A.A.):
Last name:
Institution:
City:
Country:


12. Co-Author:
First names (initials only: example A.A.):
Last name:
Institution:
City:
Country:


13. Co-Author:
First names (initials only: example A.A.):
Last name:
Institution:
City:
Country:


14. Co-Author:
First names (initials only: example A.A.):
Last name:
Institution:  
City:
Country:


15. Co-Author:
First names (initials only: example A.A.):
Last name:
Institution:
City:
Country:


                                                                                                                                                                                                                                                            
General Information:
  

*Hereby  I confirm, that this abstract has not been published before!  

* Copyright transfer to Karger Pub, Switzerland in case of acceptance is agreed   

*Conflict of interests will be disclosed!  


Please check your data carefully before submission!